Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Tags US: News Business Breaking news
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Eli Lilly and Co Health & Science Science
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Companies Social issues US: News
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Politics Merck & Co Inc Abbvie Inc
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Health & Science Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Breaking news Companies Business
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Health & Science Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Companies Business US: News
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Biotech and Pharmaceuticals Altimmune Inc Science
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Eli Lilly and Co Biotech and Pharmaceuticals Science
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Business Business News Roche Holding AG
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Eli Lilly and Co Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Pharmaceuticals Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Health care industry AstraZeneca PLC Novo Nordisk A/S
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Biotech and Pharmaceuticals Pharmaceuticals Health & Science
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Roche Holding AG Breaking News: Markets Business News
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Merck & Co Inc UnitedHealth Group Inc Healthy Returns
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Novo Nordisk A/S Eli Lilly and Co Health care industry
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Business News Breaking News: Business Health care industry
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Stock Picks Eli Lilly and Co U/S/ Markets
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Biotechnology Novo Nordisk A/S Health care industry
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Dow Jones Industrial Average Daily Open Commercial banking
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Daily Open Commercial banking JPMorgan Chase & Co
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Stock markets Mondelez International Inc Diabetes
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Deutsche Bank AG US: News Companies
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Health & Science Altimmune Inc Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Biotech and Pharmaceuticals Gilead Sciences Inc Oracle Corp
From CNBC.com News
5 things to know before the stock market opens
Tags Markets Investing Nasdaq Inc
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Eli Lilly and Co Biotech and Pharmaceuticals Europe: Top News And Analysis
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Business News Pharmaceuticals Biotechnology
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.